APA (7th ed.) Citation

WM, K., MA, R., AE, F., KT, H., DA, M., KT, K., . . . N, M. (2025). Preclinical Long-Term Stability and Forced Degradation Assessment of EPICERTIN, a Mucosal Healing Biotherapeutic for Inflammatory Bowel Disease. Pharmaceutics, 17(2), . https://doi.org/10.3390/pharmaceutics17020259

Chicago Style (17th ed.) Citation

WM, Kittle, Reeves MA, Fulkerson AE, Hamorsky KT, Morris DA, Kitterman KT, Merchant ML, and Matoba N. "Preclinical Long-Term Stability and Forced Degradation Assessment of EPICERTIN, a Mucosal Healing Biotherapeutic for Inflammatory Bowel Disease." Pharmaceutics 17, no. 2 (2025). https://doi.org/10.3390/pharmaceutics17020259.

MLA (9th ed.) Citation

WM, Kittle, et al. "Preclinical Long-Term Stability and Forced Degradation Assessment of EPICERTIN, a Mucosal Healing Biotherapeutic for Inflammatory Bowel Disease." Pharmaceutics, vol. 17, no. 2, 2025, https://doi.org/10.3390/pharmaceutics17020259.